Heron Therapeutics: 2Q Earnings Snapshot
SAN DIEGO (AP) _ Heron Therapeutics Inc. (HRTX) on Wednesday reported a loss of $55.2 million in its second quarter.
On a per-share basis, the San Diego-based company said it had a loss of 61 cents.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.
The pharmaceutical company posted revenue of $22.7 million in the period, surpassing Street forecasts. Four analysts surveyed by Zacks expected $16.4 million.
Heron Therapeutics expects full-year revenue in the range of $70 million to $80 million.
Heron Therapeutics shares have dropped 26% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $17.47, a rise of 6% in the last 12 months.